4J THERAPEUTICS INC — United States · Federal contract register · Supplier record: 1 contracts, all years ($63,083,814 · Sep 2024 – Sep 2024); $63.1M since January 2024 (1 contract · 1 agency); 2nd rank in the line (of 102 suppliers · 11.14%); 3 agencies never served ($80.8M on the line without 4J THERAPEUTICS INC).
Assay record ASY-US-0C3VX2V0E9 · Cite as: Assay Systems, “4J THERAPEUTICS INC in the USAspending register”, https://assay-systems.com/register/us/4j-therapeutics-inc/
1
contracts, all years
$63,083,814 · Sep 2024 – Sep 2024
$63.1M
since January 2024
1 contract · 1 agency
2nd
rank in the line
of 102 suppliers · 11.14%
3
agencies never served
$80.8M on the line without 4J THERAPEUTICS INC
Own record by year
2024 onward
$63.1M
202420252026
Who buys from 4J THERAPEUTICS INC
since January 2024
1agencies
$63.1Mpaid
100.0%top buyer
Department of Health and Human Services100.0%
$63,083,814
The line
since January 2024
$566Mline value
124contracts
4agencies
102suppliers
70.3%held by top ten
Health r&d services; health care services; experimental development (AN13)
$239M
$109M
$218M
202420252026Jan–Sep
2ndof 102 suppliers
$63,083,8144J THERAPEUTICS INC in the line
11.14%share of the line
13.0%of $485,502,671 spent by Department of Health and Human Services
Agencies that buy the line and never bought from 4J THERAPEUTICS INC
Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.